Tuesday, April 16, 2013

Health News: [diabetes ]: Prodigy Diabetes Care and OK Biotech Align Ownership

Yahoo! Health   |  My alerts   |   Edit Alert
Tuesday, Apr 16, 2013 12:11 PM EDT
 
   Health News : diabetes - News from Yahoo !
 
Invokana by Mitsubishi Tanabe Explored in New MP Advisors Research Report Available at Marketpublishers.com
Tue, 16 Apr, 2013 08:31 AM PDT
Invokana belongs within the new class of type 2 diabetes treatments called selective sodium glucose co-transporter 2 inhibitors. Invokana was first developed by Mitsubishi Tanabe Pharma Corporation in Japan to be later licensed to Janssen Pharmaceuticals.
Continue reading
 
   Health News : diabetes - News from other sources.
 
Prodigy Diabetes Care and OK Biotech Align Ownership
Tue, 16 Apr, 2013 08:57 AM PDT
CHARLOTTE, N.C., April 16, 2013 /PRNewswire/ -- Prodigy Diabetes Care (Prodigy) announced today that its current manufacturing partner, OK Biotech Co., Ltd., (OK Biotech) has purchased a minority stake in the company, and Prodigy acquired substantial ownership of OK Biotech's publicly...
Continue reading
Tips to Destress
Tue, 16 Apr, 2013 08:44 AM PDT
April is stress awareness month. Why should you care? Because stress is a major factor in such conditions as heart problems, diabetes, even infertility. So how do you know when you are over stressed and what can you do?
Continue reading
Takeda's Actos Diabetes Drug Increased Risk of Cancer
Tue, 16 Apr, 2013 08:38 AM PDT
According to an ongoing Actos product liability trial, in Los Angeles, the jury was told that Takeda Pharmaceutical Co., hid the cancer risks of its Actos drug to protect billions in sales. The plaintiff Jack Cooper has alleged that Takeda's internal Actos studies demonstrated links to bladder cancer in 2004,...
Continue reading
Local resident to bake and bike for JDRF
Tue, 16 Apr, 2013 08:35 AM PDT
Keith Berger will ride to raise funds for juvenile diabetes research. He'll also bake you a cheesecake.
Continue reading
Care Services, Inc. Selected as Provider of Diabetes Supplies and Equipment under Medicare Competitive Bidding Program
Tue, 16 Apr, 2013 08:29 AM PDT
CLEVELAND--(BUSINESS WIRE)--Care Services, Inc., (d.b.a. Diabetic Care Services & Pharmacy) was awarded a national mail-order contract as part of Round 2 of the Medicare Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS) Competitive Bidding Program. Care Services will provide mail-order ...
Continue reading
Eli Lilly Diabetes Drug Meets Primary Efficacy Endpoints In Late-stage Studies
Tue, 16 Apr, 2013 08:29 AM PDT
Drug maker Eli Lilly and Co. (LLY) said Tuesday that its experimental type-2 diabetes drug dulaglutide showed positive top-line results in two additional Phase III studies. The company noted that in both the studies, dulaglutide met the primary efficacy endpoints of demonstrating non-inferiority to ins...
Continue reading
Lilly reports positive results from two trials of diabetes drug
Tue, 16 Apr, 2013 07:26 AM PDT
(Reuters) - Eli Lilly and Co said two additional late-stage studies testing its experimental diabetes drug dulaglutide met the main goal of reducing hemoglobin A1c levels, a measure of blood sugar. Along with positive results from three other late-stag...
Continue reading
Prediabetes - Mornings
Tue, 16 Apr, 2013 06:26 AM PDT
This class will explain risk factors and how to lower risk of developing type 2 diabetes by up to 60 percent through dietary and lifestyle changes. Participants will receive a blood glucose meter and instruction on use.
Continue reading
Islet Sciences Issues Shareholder Update Letter
Tue, 16 Apr, 2013 06:26 AM PDT
NEW YORK--(BUSINESS WIRE)--Islet Sciences, Inc., (ISLT) a clinical stage company engaged in the research, development and commercialization of therapeutics in the field of diabetes, issued the following shareholder update letter. Islet Sciences continues to put in place a multi-faceted strategy with on...
Continue reading
You received this email because you subscribed to Yahoo! Alerts. Use this link to unsubscribe from this alert. To change your communications preferences for other Yahoo! business lines, please visit your Marketing Preferences. To learn more about Yahoo!'s use of personal information, including the use of web beacons in HTML-based email, please read our Privacy Policy. Yahoo! is located at 701 First Avenue, Sunnyvale, CA 94089.

No comments:

Post a Comment